Credit Acceptance (CACC) vs Core Scientific (CORZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Credit Acceptance (CACC) has outperformed Core Scientific (CORZ) over the past year, gaining 8.0% versus a loss of 6.8%. Credit Acceptance is the larger company by market cap ($5.53 billion vs $5.12 billion), about 1.1 times the size. On valuation, Credit Acceptance trades at a lower forward P/E (9.7x vs 97.9x for Core Scientific).
Credit Acceptance converts more of its revenue into profit, with a net margin of 18.3% versus -90.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CACC | CORZ |
|---|---|---|
| Share price | $532.55 | $15.94 |
| Market cap | $5.53B | $5.12B |
| 1-day change | -0.75% | -4.44% |
| YTD return | +20.09% | +9.48% |
| 1-year return | +8.03% | -6.78% |
| 5-year return | -13.38% | — |
| P/E ratio (TTM) | 11.82 | — |
| Forward P/E | 9.65 | 97.94 |
| EPS (TTM) | $45.05 | $-4.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.32B | $319.02M |
| Revenue growth (YoY) | +7.16% | -37.53% |
| Net income (latest FY) | $423.90M | $-288.62M |
| Gross margin | — | 11.88% |
| Operating margin | — | -76.98% |
| Net margin | 18.29% | -90.47% |
| 52-week high | $668.86 | $30.46 |
| 52-week low | $401.90 | $13.36 |
| Distance from 52-week high | -20.38% | -47.67% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +18.92% | +107.34% |
| Average volume | 124.08K | 11.83M |
| Shares outstanding | 10.38M | 321.34M |
| Employees | 2,314 | 325 |
| Sector | Financial Services | Finance |
| Industry | Credit Services | Finance: Consumer Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CACC has outperformed CORZ by 14.8 percentage points over the past year.
- Credit Acceptance is more profitable, keeping 18.3 cents of every revenue dollar as net income versus -90.5 cents for Core Scientific.
- Credit Acceptance grew revenue faster in its latest fiscal year (+7.16% vs -37.53%).
- The two companies sit in different sectors: Credit Acceptance in Financial Services and Core Scientific in Finance.
About Credit Acceptance
CACC stock →Credit Acceptance Corporation engages in the provision of financing programs, and related products and services in the United States. It advances money to automobile dealers in exchange for the right to service the underlying consumer loans; and buys the consumer loans from the dealers and keeps the amount collected from the consumers.
Financial Services · Credit Services · 2,314 employees
About Core Scientific
CORZ stock →Core Scientific, Inc. provides infrastructure for high-density colocation services and digital asset mining in the United States.
Finance · Finance: Consumer Services · 325 employees
CACC vs CORZ FAQ
Which is bigger, Credit Acceptance or Core Scientific?
Credit Acceptance (CACC) is larger, with a market capitalization of $5.53B compared with $5.12B for Core Scientific (CORZ).
Which stock has performed better over the past year, CACC or CORZ?
CACC returned +8.03% over the past 12 months, compared with -6.78% for CORZ (price return, excluding dividends). Past performance does not predict future results.
Are Credit Acceptance and Core Scientific in the same industry?
No. Credit Acceptance is in the Financial Services sector, while Core Scientific is in Finance.